Form Template Control: Quality Management System/October 26, 2021/FO-QS-0.082/Rev.01
3. The User agrees and understands that in the course of providing the services under MaxiProtect, and
in enhancing, developing and further improving or augmenting the services under MaxiProtect,
Maxicare shall engage the services of, procure products and services from, and collaborate and/or
interact with, service providers, other third parties and their respective Representatives.
4. The User, on his/her own behalf or on behalf of the Represented Member, hereby freely, knowingly
and voluntarily gives his/her consent, in accordance with the Data Privacy Laws to Maxicare, its
service provider, the Sponsoring Entity, and their respective Representatives and Authorized
Personnel to:
a. Obtain, examine, process, collect, record, organize, store, update or modify, retrieve, consult,
use, consolidate, block, erase, destroy or do any operation or set of operations on, the User or
the Represented Member data, including sensitive personal information and privileged
information, medical records, financial information which includes but not limited to banking
details, transaction numbers, payment details, or any other information or material, i.e., picture,
video and voice recording, fingerprints, CCTV and etc., relative to the User or the Represented
Member’s application and/or membership with Maxicare, availment of MaxiProtect,
hospitalization, consultation, and treatment or any medical advice in connection with the
benefit/claim availed under the Agreement/s, as may be deemed necessary by Maxicare. Except
as otherwise stated in these T&Cs, any Personal Information obtained relative to the authority
herein given shall be kept strictly confidential. The extent of the processing of Personal
Information shall be limited to what is necessary, appropriate or incidental to the performance
of the services under MaxiProtect as contemplated in the Agreements and these T&Cs.
b. Process and disclose such Personal Information to the Sponsoring Entity, Maxicare, their
respective Representatives, and Authorized Personnel, as well as relevant government agencies
in compliance with Republic Act No. 11223, otherwise known as the “Universal Health Care Act”,
its Implementing Rules and Regulations, Republic Act No. 11332, otherwise known as the
“Mandatory Reporting of Notifiable Diseases and Health Events of Public Health Concern Act”,
Republic Act No. 11525, otherwise known as the “Covid-19 Vaccination Program Act of 2021,”,and
other relevant issuances of the Department of Health, Food and Drug Administration, and/or
Philippine Health Insurance Corporation (“Philhealth”), and any amendments to such laws,
rules, regulations, and issuances, for any legitimate business purpose as Maxicare may deem
appropriate, including but not limited to outsourced processing of Maxicare transactions,
disclosure to and transacting with lifestyle and rewards partners/providers, profiling or historical
statistical analysis, providing advice or information which Maxicare, its Representatives and/or
Authorized Personnel believe may be of interest to the User or to the Represented Member,
administering or managing User or the Represented Member’s accounts, enhancing customer
services, or communicating with such User or Represented Member for any marketing purposes.
c. Process and disclose information on adverse drug reactions and/or events the User, the
Represented Member, or Member Representative reported via MaxiProtect and/or the App,
which may be transformed into an anonymized and aggregate form, to drug manufacturers from
which Maxicare procured, directly or through other providers, the vaccines administered, strictly
for the purposes of Pharmacovigilance.
For clarity, processing would include both manual and automated handling, storage and transfer of
Personal Information using various means and methods whether physical or electronic (via
information and communications systems employed by Maxicare and its Representatives).